A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment
Clinical trial NCT00002243 · COMPLETED
Trial details
- NCT number
- NCT00002243
- Sponsor
- Sarawak MediChem Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.